Clinical trial
Impact of Dapagliflozin on Vascular Function in Chronic Kidney Disease Patients
NCT04930549 is registered in ClinicalTrials.gov with University Hospital, Rouen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Dapagliflozin on Vascular Function in Chronic Kidney Disease Patients
- Lead sponsor
- University Hospital, Rouen
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 18, 2022
- Completion date
- September 23, 2024
- Enrollment
- 32 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.